FrancophonIA/ELRC3.0 huggingface dataset:
English: Mycophenolate is a powerful human teratogen, with an increased risk of spontaneous abortions and congenital malformations in case of exposure during pregnancy;
Maltese: Mycophenolate huwa teratoġen qawwi fil-bnedmin, b'żieda fir-riskju ta' aborti spontanji u malformazzjonijiet konġenitali f'każ ta' esponiment waqt it-tqala:
English: Isavuconazole An increase of MPA AUC0-∞ by 35% was observed with concomitant administration of isavuconazole.
Maltese: Isavuconazole Żieda ta' 35% fl-AUC0-∞ ta' MPA ġiet osservata bl-għoti fl-istess waqt ma' isavuconazole.
English: Pharmacokinetic behaviour of mycophenolate mofetil in the elderly (≥°65 years) has not been formally evaluated.
Maltese: Anzjani L-imġieba farmakokinetika ta' mycophenolate mofetil fl-anzjani (≥ 65 sena) ma ġietx formalment evalwata.
English: Patients treated with immunosuppressants, including Mycophenolate mofetil Teva, are at increased risk for opportunistic infections (bacterial, fungal, viral and protozoal), fatal infections and sepsis (see section 4.8).
Maltese: Pazjenti trattati b'immunosoppressanti, inkluż Mycophenolate mofetil Teva, huma f'riskju akbar għall-infezzjonijiet opportunistiċi (mill-batterja, moffa, virus u protożoa), infezzjonijiet fatali u sepsis (ara sezzjoni 4.8).
English: Mycophenolate mofetil Teva contains sodium
Maltese: Mycophenolate mofetil Teva fih sodium
English: Studies in animals have shown reproductive toxicity (see section 5.3).
Maltese: Studji fl-annimali wrew tossiċità reproduttiva (ara sezzjoni 5.3). Treddigħ
English: Decrease in MPA Cmax and AUC0-12h by 30% and 25%, respectively, were observed when mycophenolate mofetil was concomitantly administered with sevelamer without any clinical consequences (i.e. graft rejection).
Maltese: Tnaqqis f'Cmax u AUC0-12h ta' MPA bi 30 % u 25 % rispettivament kienu osservati meta mycophenolate mofetil kien mogħti flimkien ma' sevelamer mingħajr konsegwenzi kliniċi (i.e. riġettazzjoni tat-trapjant).
English: • The other ingredients are:
Maltese: • Qed tieħu xi mediċini li fihom:
English: Organic anion transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are involved in MPA's disposition; OATP isoforms, MRP2 and breast cancer resistance protein (BCRP) are transporters associated with the glucuronides' biliary excretion.
Maltese: MPA; isoformi ta' OATP, MRP2 u proteina ta' reżistenza għall-kanċer tas-sider (BCRP - breast cancer resistance protein) huma trasportaturi assoċjati mat-tneħħija biljari ta' glucuronides.
English: Very commonCommon
Maltese: Komuni ħafnaCommon
English: Mycophenolate mofetil has been associated with an increased incidence of digestive system adverse events, including infrequent cases of gastrointestinal tract ulceration, haemorrhage and perforation.
Maltese: Mycophenolate mofetil ġie assoċjat ma' inċidenza akbar ta' reazzjonijiet avversi tas-sistema diġestiva, inkluż każi mhux tas-soltu ta' ulċerazzjoni tat-tubi gastrointestinali, emorraġija u perforazzjoni.
English: It is recommended that the second test should be performed 8-10 days after the first test. For transplants from deceased donors, if it is not possible to perform two tests 8-10 days apart before treatment starts (because of the timing of transplant organ availability), a pregnancy test must be performed immediately before starting treatment and a further test performed 8-10 days later.
Maltese: Għal trapjanti minn donaturi mejtin, jekk ma jkunx possibbli li jsiru żewġ testijiet 8 - 10 ijiem bogħod minn xulxin qabel ma jibda t-trattament (minħabba ż-żmien tad-disponibilità tal-organu li se jiġi trapjantat), għandu jsir test tat-tqala eżatt qabel ma jinbeda t-trattament u test ieħor għandu jsir 8 - 10 ijiem wara.
English: Hypersensitivity reactions to Mycophenolate mofetil Teva have been observed (see section 4.8).
Maltese: Mycophenolate mofetil Teva huwa rakkomandat (ara sezzjoni 4.4).
English: The recommended dose is 600°mg/m2 taken twice a day.
Maltese: 20 mg/kg/day.
English: • if you are allergic to mycophenolate mofetil, mycophenolic acid or any of the other ingredients of this medicine (listed in section 6).
Maltese: • jekk inti allerġiku għal mycophenolate mofetil, mycophenolic acid għal xi jew sustanza oħra ta' din il-mediċina (elenkati f-sezzjoni 6).
English: Non-melanoma skin carcinomas occurred in 3.6% of patients; other types of malignancy occurred in 1.1% of patients.
Maltese: Karsinomi (mhux melanoma) tal ġilda seħħew fi 3.6% tal-pazjenti; tipi oħra ta' mard malinn seħħew f'1.1%.
English: Two genotoxicity assays (in vitro mouse lymphoma assay and in vivo mouse bone marrow micronucleus test) showed a potential of mycophenolate mofetil to cause chromosomal aberrations.
Maltese: Żewġ assaysi fuq ġenotossicità (assaġġ in vitro f'limfoma tal-ġrieden u in vivo mikronuklejus test fil-mudullun tal-ġrieden) urew potenzjal ta' mycophenolate mofetil li jikkawża aberrazzjonijiet.
English: • Your fallopian tubes and both ovaries have been removed by surgery (bilateral salpingooophorectomy).
Maltese: • It-tubi fallopjani tiegħek u ż-żewġ ovarji tneħħew permezz ta' operazzjoni (salpingo-oophorectomy bilaterali).
English: The type and frequency of adverse reactions in a clinical study, which recruited 92 paediatric patients aged 2 to 18°years who were given 600°mg/m2 mycophenolate mofetil orally twice daily, were generally similar to those observed in adult patients given 1°g mycophenolate mofetil twice daily.
Maltese: It-tip u l-frekwenza ta' reazzjonijiet avversi fi studju kliniku, fejn ġew ingaġġati 92 pazjent pedjatriku bejn l-etajiet ta' 2-18-il sena li ngħataw 600 mg/m2 mycophenolate mofetil oralment darbtejn kuljum,
English: Contraception in men taking Mycophenolate mofetil Teva
Maltese: Mediċini oħra u Mycophenolate mofetil Teva
English: Paediatric population aged 2 to 18 years The recommended dose of mycophenolate mofetil is 600 mg/m2 administered orally twice daily (up to a maximum of 2°g daily).
Maltese: Id-doża rakkomandata ta' mycophenolate mofetil hija ta' 600 mg/m2 li tingħata mill-ħalq darbtejn kuljum (sa' massimu ta' 2 g kuljum).
English: Before starting Mycophenolate mofetil Teva treatment, women of childbearing potential must have two negative serum or urine pregnancy tests with a sensitivity of at least 25 mIU/mL in order to exclude unintended exposure of the embryo to mycophenolate.
Maltese: Qabel ma jinbeda trattament b'Mycophenolate mofetil Teva, nisa li jistgħu joħorġu tqal għandu jkollhom żewġ testijiet tat-tqala tas-serum jew tal-awrina negattivi b'sensittività ta' mill-inqas 25 mIU/mL negattivi sabiex jiġi eskluż esponiment mhux intenzjonat tal-embriju għal mycophenolate.
English: However, norfloxacin and metronidazole combined reduced the MPA exposure by approximately 30% following a single dose of mycophenolate mofetil.
Maltese: Madanakollu, norfloxacin u metronidazole flimkien naqqsu l-esponiment għal MPA b'madwar 30% wara doża waħda ta'
English: The systemic exposure at this dose represents 2-3°times the clinical exposure at the recommended clinical dose of 2 g/day in renal transplant patients and 1.3-2°times the clinical exposure at the recommended clinical dose of 3 g/day in cardiac transplant patients.
Maltese: L-espożizzjoni sistemika f'din id-doża tirrappreżenta 2-3 darbiet l-espożizzjoni klinika fid-doża klinika rakkomandata ta' 2 g/kuljum f'pazjenti bi trapjanti tal-kliewi u 1.3 - 2 darbiet l espożizzjoni klinika fid-doża klinika rakkomandata ta' 3 g/kuljum f'pazjenti bi trapjanti tal-qalb.
English: The highest dose tested in the animal carcinogenicity studies resulted in approximately 2-3 times the systemic exposure (AUC or Cmax) observed in renal transplant patients at the recommended clinical dose of 2 g/day and 1.3-2°times the systemic exposure (AUC or Cmax) observed in cardiac transplant patients at the recommended clinical dose of 3 g/day.
Maltese: L-ogħla doża ttestjata fi stħarriġ fuq il-karċinogenetiċità fl-annimali rriżultat f'bejn wieħed u ieħor 2-3 darbiet l-esponiment sistemiku (AUC jew Cmax) osservat f'pazjenti bi trapjanti tal-kliewi f'doża klinika rakkomandata ta' 2 g/kuljum u 1.3 - 2 darbiet l-esponimet sistemiku (AUC jew Cmax) osservat f'pazjenti bi trapjanti tal qalb f'doża klinika rakkomandata ta' 3 g/kuljum.
English: How to take Mycophenolate mofetil Teva
Maltese: Tiħux Mycophenolate mofetil Teva
English: By interfering with enterohepatic circulation of the drug, bile acid sequestrants such as cholestyramine, reduce MPA AUC (see section 4.9).
Maltese: Billi jfixklu r-riċiklaġġ enterepatiku tal-mediċina, sekwestranti tal aċidi tal-bili bħal cholestyramine, inaqqsu l-AUC ta' MPA (ara sezzjoni 4.9).
English: Pneumonia, influenza, respiratory tract infection, respiratory moniliasis, gastrointestinal infection, candidiasis, gastroenteritis, infection, bronchitis, pharyngitis, sinusitis, fungal skin infection, skin candida, vaginal candidiasis, rhinitis
Maltese: bronkite, farinġite, sinusite, infezzjoni fungali talġilda, kandida tal-ġilda, kandidjasi vaġinali, rinite
English: In a female fertility and reproduction study conducted in rats, oral doses of 4.5 mg/kg/day caused malformations (including anophthalmia, agnathia and hydrocephaly) in the first generation offspring in the absence of maternal toxicity.
Maltese: Fi stħarriġ fuq il-fertilità u r-riproduzzjoni magħmul fuq firien nisa, dożi orali ta' 4.5 mg/kg/day ikkaġunaw malformazzjonijiet (inklużi anoftalmja, agnatija u idrokefali) f'wild tal-ewwel ġenerazzjoni fl-assenza ta' tossiċità materna.
English: • You were born with one of the following rare conditions that make pregnancy impossible: the XY genotype, Turner`s syndrome or uterine agenesis.
Maltese: • Twelidt b'waħda mill-kondizzjonijiet rari li ġejjin li jagħmlu t-tqala impossibbli: il-ġenotip XY, is sindrome ta' Turner jew aġenesi tal-utru.
English: Mycophenolate mofetil Teva 250mg hard capsules Mycophenolate mofetil
Maltese: Mycophenolate mofetil Teva 250mg kapsuli iebsin Mycophenlate mofetil
English: The antibody response to other vaccines may be diminished (see also section 4.4).
Maltese: Ir rispons tal-antikorpi għal tilqim ieħor jista' jkun imnaqqas (ara wkoll sezzjoni 4.4).
English: Mycophenolate mofetil Teva should not be used in children and adolescents (aged 2 to 18) for heart or liver transplantation.
Maltese: Mycophenolate mofetil Teva m'għandux jintuża fi tfal u adoloxxenti (b'età minn 2 sa 18-il sena) għal trapjanti tal-qalb jew fwied.
English: Mycophenolate mofetil Teva should not be used during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection (see section 4.6).
Maltese: Mycophenolate mofetil Teva m'għandux jintuża waqt it-tqala ħlief jekk ma jkunx disponibbli trattament alternattiv xieraq biex jiġi evitat rifjut tat-trapjant (ara sezzjoni 4.6).
English: Mycophenolate mofetil Teva is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Maltese: Mycophenolate mofetil Teva hu indikat flimkien ma' ciclosporin u corticosteroids għall-profilassi ta' riġezzjoni akuta ta' trapjanti f'pazjenti li jirċievu trapjanti renali, kardijaċi jew epatiċi alloġeniċi.
English: • The active substance is mycophenolate mofetil.
Maltese: • Is-sustanza attiva hi 500 mg mycophenolate mofetil.
English: Mycophenolate mofetil Teva should not be given to women of childbearing potential who are not using highly effective contraception (see section 4.6).
Maltese: Mycophenolate mofetil Teva m'għandux jingħata lil nisa li jistgħu joħorġu tqal li ma jkunux qed jużaw kontraċezzjoni effettiva ħafna (ara sezzjoni 4.6).
English: Gastrointestinal and renal effects consistent with dehydration were also observed in the monkey at the highest dose (systemic exposure levels equivalent to or greater than clinical exposure).
Maltese: deidrazzjoni kienu ukoll osservati fix-xadini fl-għola doża (livelli sistemiċi ta' espozizzjoni ekwivalenti għal jew akbar minn l-espożizzjoni klinika).
English: Capsule content Pregelatinised starch (maize) Povidone K-30
Maltese: Pregelatinised maize starch (qamħirrum)
English: Patients with a body surface area of 1.25 to 1.5 m2 may be prescribed Mycophenolate mofetil Teva capsules at a dose of 750 mg twice daily (1.5 g daily dose).
Maltese: Il-kapsuli Mycophenolate mofetil Teva għandhom jiġu biss preskritti lil pazjenti b'erja superfiċjali korporali ta' minn l-anqas 1.25 m2. Pazjenti b'erja superfiċjali korporali ta' bejn 1.25-1.5 m2 għandhom jiġu ppreskritti l-kapsuli Mycophenolate mofetil Teva f'doża ta' 750 mg darbtejn kuljum (doża ta' 1.5 g kuljum).
English: Mycophenolate mofetil Teva 250 mg hard capsules are available in PVC/PVdC-aluminium blisters in pack sizes of 100 or 300 or 100 x 1 capsules per carton.
Maltese: Ir-ras: kaħlanija ċara opaka li fuqha hemm stampat “M” b'mod assjali b'linka sewda. Mycophenolate mofetil Teva 250 mg kapsuli iebsin jiġu f'pakketti tal-folji tal-PVC/PVdC-aluminju f'daqsijiet ta' 100, 300 jew 100x1 kapsula f'kull kartuna Jista' jkun li mhux il-pakketti tad-daqsijiet kollha jkunu fis-suq.
English: What is in this leaflet:
Maltese: • Għoti ta' pariri lill-pazjenti:
English: Mycophenolate mofetil Teva 500mg film-coated tablets Mycophenolate mofetil
Maltese: Mycophenolate mofetil Teva 500mg pilloli miksijin b'rita Mycophenolate mofetil
English: Mycophenolate causes a very high frequency of miscarriage (50%) and of severe birth defects (23-27%) in the unborn baby.
Maltese: Tqala Mycophenolate jikkawża frekwenza għolja ħafna ta' korriment (50%) u ta' difetti severi tat-twelid
English: Elderly patients receiving Mycophenolate mofetil Teva as part of a combination immunosuppressive regimen may be at increased risk of certain infections (including cytomegalovirus tissue invasive disease) and possibly gastrointestinal haemorrhage and pulmonary oedema, compared to younger individuals.
Maltese: Pazjenti anzjani li qegħdin jingħataw Mycophenolate mofetil Teva bħala parti minn reġimen immunosoppressiv kkombinat jistgħu jkunu f'riskju akbar ta' ċertu infezzjonijiet (li jinkludu mard ta' invażjoni tat-tessuti minn cytomegalovirus) u possibilment t'emorraġija gastrointestinali u edema pulmonarja, meta mqabblin ma' individwi aktar żgħar.
English: Precautions to be taken before handling or administering the medicinal product Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Mycophenolate mofetil Teva capsules should not be opened or crushed to avoid inhalation or direct contact with skin or mucous membranes of the powder contained in Mycophenolate mofetil Teva capsules.
Maltese: Peress li mycophenolate mofetil wera effetti teratoġeniċi fil-firien u l-fniek, kapsuli Mycophenolate mofetil Teva m'għandhomx jinfetħu jew jitfarrku biex jiġi evitat teħid man-nifs jew kuntatt dirett malġilda jew ma' membrani mukużi tat-trab li jinsab f'kapsuli Mycophenolate mofetil Teva.
English: Gastrointestinal effects were observed in the dog at systemic exposure levels equivalent to or less than the clinical exposure at the recommended doses.
Maltese: Effetti gastrointestinali kienu osservati fil-klieb f'livelli ta' espożizzjoni sistemiċi ekwivalenti għal jew anqas minn lespożizzjoni klinika fid-dożi rakkomandati.
English: In contrast, there was an increase of approximately 20% in tacrolimus AUC when multiple doses of mycophenolate mofetil (1.5°g taken twice a day [BID], morning and evening) were administered to hepatic transplant patients taking tacrolimus.
Maltese: B'kuntrast, kien hemm żjieda ta' madwar 20 % fl-AUC ta' tacrolimus meta dożi multipli ta' mycophenolate mofetil (1.5 g [BID], filgħodu u filgħaxija) ingħataw lil pazjenti li kellhom trapjant tal-fwied li kienu qed jieħdu tacrolimus.
English: Mycophenolate mofetil Teva 500 mg film-coated tablets Mycophenolate mofetil
Maltese: Kull pillola fiha 500 mg mycophenolate mofetil
English: If neutropenia develops (absolute neutrophil count <°1.3°x 103/°µl) it may be appropriate to interrupt or discontinue Mycophenolate mofetil Teva.
Maltese: Jekk tiżviluppa n-newtropenija (għadd ta' newtrofils assolut < 1.3 103/µL) jkun aħjar li Mycophenolate mofetil Teva jiġi interrot jew imwaqqaf.
English: The capsule body is caramel opaque, printed with ‘250' axially in black ink.
Maltese: Kapsuli iebsin Il-korp: lewn il-karamelli opak, li fuqu hemm stampat ‘250' b'mod assjali b'linka sewda
English: Therefore Mycophenolate mofetil Teva is contraindicated in pregnancy unless there are no suitable alternative treatments to prevent transplant rejection.
Maltese: Għalhekk Mycophenolate mofetil Teva huwa kontraindikat waqt it-tqala ħlief jekk ma jkunux disponibbli trattamenti alternattivi xierqa biex jiġi evitat rifjut tat-trapjant.
English: Based on the results of a single dose administration study of recommended doses of oral mycophenolate mofetil and intravenous ganciclovir and the known effects of renal impairment on the pharmacokinetics of mycophenolate mofetil (see section 4.2) and ganciclovir, it is anticipated that coadministration of these agents (which compete for mechanisms of renal tubular secretion) will result in increases in MPAG and ganciclovir concentration.
Maltese: Ibbażat fuq ir-riżultati ta' stħarriġ b'għoti ta' doża ewlenija tad-dożi rakkomandati ta' mycophenolate mofetil b'mod orali u ganciclovir intravenuż u l-effetti magħrufa dwar l-indeboliment tal-kliewi fuq il farmakokinetiċi ta' mycophenolate mofetil (ara sezzjoni 4.2) u ganciclovir, huwa antiċipat li l-għoti konkomittanti ta' dawn iż-żewġ mediċini (li jikkompetu għall-mekaniżmi ta' tnixxija mit-tubuli tal kliewi) tirriżulta f'żidiet fil-konċentrazzjonijiet ta' MPAG u ganciclovir.
English: Pregnancy, puerperium and perinatal conditions Cases of spontaneous abortions have been reported in patients exposed to mycophenolate mofetil, mainly in the first trimester, see section 4.6.
Maltese: Każijiet ta' abort spontanju kienu irrappurtati f'pazjenti esposti għal mycophenolate mofetil, il-biċċa lkbira fl-ewwel trimester, ara sezzjoni 4.6.
English: Men must not donate semen during treatment with Mycophenolate mofetil Teva and for at least 90°days after stopping treatment.
Maltese: Irġiel m'għandhomx jagħtu semen waqt it-trattament b'Mycophenolate mofetil Teva u għal mill-inqas 90 jum wara li jitwaqqaf it-trattament.
English: Do not take Mycophenolate mofetil Teva,
Maltese: Mycophenolate mofetil Teva.
English: Neoplasms
Maltese: FARMAĊEWTIKU
English: Mycophenolate mofetil Teva is contraindicated during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection.
Maltese: Mycophenolate mofetil Teva huwa kontraindikat waqt it-tqala ħlief jekk ma jkunx hemm trattament alternattiv xieraq biex jiġi evitat rifjut tat-trapjant.
English: Indigo carmine (E132)
Maltese: Indigo carmine (E132) Titanium dioxide (E171) Gelatin
English: Patients with a body surface area greater than 1.5 m2 may be prescribed Mycophenolate mofetil Teva capsules at a dose of 1 g twice daily (2 g daily dose).
Maltese: Pazjenti b' erja superfiċjali korporali akbar minn 1.5 m2 għandhom jiġu ppreskritti l-kapsuli Mycophenolate mofetil Teva f'doża ta' 1 g darbtejn kuljum (doża ta' 2 g kuljum).
English: Because of the potential for serious adverse reactions to mycophenolate mofetil in breast-fed infants, Mycophenolate mofetil Teva is contraindicated in breast-feeding mothers (see section 4.3).
Maltese: Minħabba fir-riskju potenzjali għarreazzjonijiet avversi serji għal mycophenolate mofetil fi trabi li jkunu mredda', Mycophenolate mofetil Teva huwa kontra-indikat f'ommijiet li jkunu qegħdin ireddgħu (ara sezzjoni 4.3).
English: Mycophenolate mofetil Teva treatment should not be initiated in women of child bearing potential without providing a pregnancy test result to rule out unintended use in pregnancy (see section 4.6).
Maltese: Trattament b'Mycophenolate mofetil Teva m'għandux jinbeda f'nisa li jistgħu joħorġu tqal mingħajr ma jiġi pprovdut riżultat ta' test tat-tqala biex jiġi żgurat li ma jintużax b'mod mhux intenzjonat waqt it-tqala (ara sezzjoni 4.6).
English: Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation and infections caused by polyomaviruses (BK virus associated nephropathy, JC virus associated progressive multifocal leukoencephalopathy PML).
Maltese: Infezzjonijiet bħal dawn jinkludu attivazzjoni mill-ġdid ta' virusis mhux attivi, bħal attivazzjoni mill-ġdid tal-epatite B jew tal-epatite Ċ u infezzjonijiet ikkawżati minn poliomavirusis (nefropatija assoċjata mal-virus BK, lewkoenċefalopatija multifokali progressiva
English: In volunteers with alcoholic cirrhosis, hepatic MPA glucuronidation processes were relatively unaffected by hepatic parenchymal disease.
Maltese: Indeboliment epatiku F'voluntieri b'ċirrożi alkoħolika, proċessi ta' glukorinazzjoni ta' MPA epatiċi kienu relativament mhux effettwati minn mard epatiku parenkimali.
English: The recommended dose in cardiac transplant patients is 1.5°g administered twice daily (3°g daily dose).
Maltese: Iddoża rakkomandata f'pazjenti bi trapjant kardijaku hi ta' 1.5 g li tingħata darbtejn kuljum (doża ta' 3 g kuljum).
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Maltese: • Rapporti Perjodiċi Aġġornati dwar is-Sigurtà Ir-rekwiżiti tar-rapporti perjodiċi aġġornati dwar is-sigurtà għal dan il-prodott mediċinali huma mniżżla fil-lista tad-dati ta' referenza tal-Unjoni (lista EURD) prevista skont l-Artikolu 107c(7)
English: Hard capsule (capsule)
Maltese: X'tikkonsisti l-kapsula
English: Two forms of contraception are preferable as this will reduce the risk of unintended pregnancy.
Maltese: Żewġ forom ta' kontraċezzjoni huma preferibbli għax dan inaqqas ir riskju ta' tqala mhux intenzjonata.
English: • chest cold, sore throat, inflammation of the sinuses, stuffy and runny nose, sneezing
Maltese: • rimettar, uġigħ fl-istonku, dijarea, tħossok imdardar
English: Therefore women of childbearing potential must use at least one form of reliable contraception (see section 4.3) before starting Mycophenolate mofetil Teva therapy, during therapy, and for six weeks after stopping the therapy, unless abstinence is the chosen method of contraception.
Maltese: kontraċezzjoni affidabbli (ara sezzjoni 4.3) qabel ma tinbeda terapija b'Mycophenolate mofetil Teva waqt it-terapija u għal sitt ġimgħat wara li titwaqqaf it-terapija, sakemm l-astinenza ma tkunx il metodu magħżul ta' kontraċezzjoni.
English: Agranulocytosis (≥1/1000 to <1/100) and neutropenia have been reported; therefore regular monitoring of patients taking Mycophenolate mofetil Teva is advised (see section 4.4).
Maltese: Agranuloċitosi (≥1/1,000 to <1/100) u newtropenija ġew irrapportati: għalhekk moniteraġġ tal-pazjenti li qegħdin jieħdu
English: • Olfactory nerve agenesis.
Maltese: .9 Effetti mhux mixtieqa
English: Cap
Maltese: UŻU
English: Mycophenolate mofetil Teva is used in children and adolescents (aged 2 to 18) to prevent a body rejecting a transplanted kidney.
Maltese: Mycophenolate mofetil Teva jintuża fi tfal u adoloxxenti (b'età minn 2 sa 18-il sena) biex jipprevjeni r-riġessjoni mil-ġisem ta kilwa trapjantata
English: Atazanavir Krka is available as capsules (150 mg, 200 mg and 300 mg).
Maltese: Krka jiġi f'kapsuli (150 mg, 200 mg u 300 mg).
English: Further information on Atazanavir Krka can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/atazanavir-krka.
Maltese: ema.europa.eu/medicines/human/EPAR/atazanavir-krka.
English: Atazanavir Krka is an HIV medicine used to treat patients infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immunodeficiency syndrome (AIDS).
Maltese: Krka huwa mediċina għall-HIV użat biex jikkura pazjenti infettati bil-virus talimmunodefiċjenza tal-bniedem tat-tip 1 (HIV-1), virus li jikkawża s-sindrome mill-immunodefiċjenza akkwiżita (AIDS).
English: For adults, the recommended dose is 300 mg once a day.
Maltese: Għall-adulti, id-doża rakkomandata hija 300 mg darba kuljum.